(HCA) HCA Holdings - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US40412C1018
HCA: Hospitals, Healthcare, Services, Facilities, Clinics, Therapy
HCA Healthcare, Inc. stands as a formidable player in the healthcare sector, operating a vast network of medical facilities across the United States. Through its subsidiaries, the company manages a diverse array of healthcare entities, underscoring its significant presence in the industry. With a rich history dating back to its founding in 1968, HCA Healthcare is headquartered in Nashville, Tennessee, and has grown into one of the largest healthcare providers in the world, operating over 180 hospitals and numerous outpatient facilities, generating over $50 billion in annual revenue.
The companys service offerings are comprehensive, encompassing general and acute care hospitals that provide essential medical and surgical services. These services include inpatient care, intensive care, cardiac services, diagnostics, and emergency care. Additionally, HCA Healthcare extends its reach into outpatient services, such as surgery, laboratory testing, radiology, respiratory therapy, cardiology, and physical therapy. This diversification highlights HCAs commitment to providing accessible care across various patient needs.
Furthermore, HCA Healthcare operates an extensive network of freestanding ambulatory surgery centers, emergency care facilities, urgent care clinics, and walk-in centers. These outpatient facilities also include diagnostic and imaging centers, rehabilitation centers, oncology treatment centers, and physician practices. This strategic diversification allows HCA to cater to a wide range of healthcare requirements, from immediate care to specialized treatments.
Expanding beyond traditional medical services, HCA Healthcare also operates behavioral health hospitals. These facilities offer crucial therapeutic programs tailored to different demographics, including child, adolescent, and adult psychiatric care. They also provide specialized treatment for substance abuse and counseling services, addressing the growing need for mental health support in the communities they serve.
From a financial standpoint, HCA Healthcare presents an intriguing profile for investors. With a market capitalization exceeding $82 billion, the company demonstrates substantial scale and stability. The forward P/E ratio of 13.00 suggests a reasonable valuation, indicating potential for future growth. The price-to-book ratio, while elevated at 293.44, reflects the companys significant intangible assets and operational efficiency. The price-to-sales ratio of 1.18 underscores a balanced revenue generation capability relative to its market valuation.
In summary, HCA Healthcare, Inc. is a cornerstone of the American healthcare system, offering a broad spectrum of medical services through its extensive network of facilities. Its strategic diversification and robust financial metrics make it a notable entity for both investors and industry observers. As the healthcare landscape continues to evolve, HCA Healthcares adaptability and comprehensive service offerings position it as a resilient player in the sector.
Additional Sources for HCA Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
HCA Stock Overview
Market Cap in USD | 78,528m |
Sector | Healthcare |
Industry | Medical Care Facilities |
GiC Sub-Industry | Health Care Facilities |
IPO / Inception | 2011-03-10 |
HCA Stock Ratings
Growth 5y | 67.3% |
Fundamental | 46.2% |
Dividend | 49.1% |
Rel. Strength Industry | 0.06 |
Analysts | 4.2/5 |
Fair Price Momentum | 326.41 USD |
Fair Price DCF | 524.68 USD |
HCA Dividends
Dividend Yield 12m | 0.81% |
Yield on Cost 5y | 1.97% |
Annual Growth 5y | 27.94% |
Payout Consistency | 53.4% |
HCA Growth Ratios
Growth Correlation 3m | 3.8% |
Growth Correlation 12m | 9.7% |
Growth Correlation 5y | 91% |
CAGR 5y | 18.66% |
CAGR/Max DD 5y | 0.36 |
Sharpe Ratio 12m | 0.04 |
Alpha | -9.90 |
Beta | 0.49 |
Volatility | 28.89% |
Current Volume | 1638.6k |
Average Volume 20d | 1674.5k |
As of February 22, 2025, the stock is trading at USD 316.42 with a total of 1,638,585 shares traded.
Over the past week, the price has changed by +0.07%, over one month by -0.64%, over three months by -4.56% and over the past year by +2.33%.
Partly, yes. Based on ValueRay Fundamental Analyses, HCA Holdings (NYSE:HCA) is currently (February 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 46.21 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of HCA as of February 2025 is 326.41. This means that HCA is currently overvalued and has a potential downside of 3.16%.
HCA Holdings has received a consensus analysts rating of 4.20. Therefor, it is recommend to buy HCA.
- Strong Buy: 15
- Buy: 3
- Hold: 5
- Sell: 1
- Strong Sell: 1
According to ValueRays Forecast Model, HCA HCA Holdings will be worth about 361.4 in February 2026. The stock is currently trading at 316.42. This means that the stock has a potential upside of +14.23%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 374.9 | 18.5% |
Analysts Target Price | 392.2 | 23.9% |
ValueRay Target Price | 361.4 | 14.2% |